vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and ORRSTOWN FINANCIAL SERVICES INC (ORRF). Click either name above to swap in a different company.

ORRSTOWN FINANCIAL SERVICES INC is the larger business by last-quarter revenue ($64.6M vs $49.9M, roughly 1.3× MARAVAI LIFESCIENCES HOLDINGS, INC.). ORRSTOWN FINANCIAL SERVICES INC runs the higher net margin — 33.8% vs -71.6%, a 105.3% gap on every dollar of revenue. Over the past eight quarters, ORRSTOWN FINANCIAL SERVICES INC's revenue compounded faster (39.3% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Orrstown Financial Services Inc is a US regional bank holding company headquartered in Shippensburg, Pennsylvania. It offers a full range of retail and commercial banking solutions including deposit accounts, personal and business loans, mortgages, and wealth management services, primarily serving customers across central Pennsylvania and northern Maryland.

MRVI vs ORRF — Head-to-Head

Bigger by revenue
ORRF
ORRF
1.3× larger
ORRF
$64.6M
$49.9M
MRVI
Higher net margin
ORRF
ORRF
105.3% more per $
ORRF
33.8%
-71.6%
MRVI
Faster 2-yr revenue CAGR
ORRF
ORRF
Annualised
ORRF
39.3%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MRVI
MRVI
ORRF
ORRF
Revenue
$49.9M
$64.6M
Net Profit
$-35.7M
$21.8M
Gross Margin
25.8%
Operating Margin
-117.9%
Net Margin
-71.6%
33.8%
Revenue YoY
-11.8%
Net Profit YoY
-37.7%
19.1%
EPS (diluted)
$-0.24
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
ORRF
ORRF
Q1 26
$64.6M
Q4 25
$49.9M
$64.9M
Q3 25
$41.6M
$64.4M
Q2 25
$47.4M
$62.4M
Q1 25
$46.9M
$60.4M
Q4 24
$56.6M
$61.8M
Q3 24
$69.0M
$64.1M
Q2 24
$69.4M
$33.3M
Net Profit
MRVI
MRVI
ORRF
ORRF
Q1 26
$21.8M
Q4 25
$-35.7M
$21.5M
Q3 25
$-25.6M
$21.9M
Q2 25
$-39.6M
$19.4M
Q1 25
$-29.9M
$18.1M
Q4 24
$-25.9M
$13.7M
Q3 24
$-97.1M
$-7.9M
Q2 24
$-9.8M
$7.7M
Gross Margin
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Operating Margin
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
-117.9%
42.3%
Q3 25
-98.6%
43.0%
Q2 25
-139.8%
39.6%
Q1 25
-104.9%
37.7%
Q4 24
-66.7%
27.7%
Q3 24
-239.9%
-15.4%
Q2 24
-19.4%
29.5%
Net Margin
MRVI
MRVI
ORRF
ORRF
Q1 26
33.8%
Q4 25
-71.6%
33.1%
Q3 25
-61.4%
34.0%
Q2 25
-83.5%
31.2%
Q1 25
-63.9%
29.9%
Q4 24
-45.8%
22.1%
Q3 24
-140.6%
-12.3%
Q2 24
-14.1%
23.3%
EPS (diluted)
MRVI
MRVI
ORRF
ORRF
Q1 26
$1.12
Q4 25
$-0.24
$1.11
Q3 25
$-0.18
$1.13
Q2 25
$-0.27
$1.01
Q1 25
$-0.21
$0.93
Q4 24
$-0.21
$0.35
Q3 24
$-0.68
$-0.41
Q2 24
$-0.07
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
ORRF
ORRF
Cash + ST InvestmentsLiquidity on hand
$216.9M
$161.8M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$603.2M
Total Assets
$770.6M
$5.6B
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
ORRF
ORRF
Q1 26
$161.8M
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Total Debt
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Stockholders' Equity
MRVI
MRVI
ORRF
ORRF
Q1 26
$603.2M
Q4 25
$212.4M
$591.5M
Q3 25
$245.4M
$571.9M
Q2 25
$265.9M
$548.4M
Q1 25
$300.6M
$532.9M
Q4 24
$325.3M
$516.7M
Q3 24
$344.9M
$516.2M
Q2 24
$434.7M
$278.4M
Total Assets
MRVI
MRVI
ORRF
ORRF
Q1 26
$5.6B
Q4 25
$770.6M
$5.5B
Q3 25
$849.2M
$5.5B
Q2 25
$897.0M
$5.4B
Q1 25
$959.8M
$5.4B
Q4 24
$1.0B
$5.4B
Q3 24
$1.3B
$5.5B
Q2 24
$1.4B
$3.2B
Debt / Equity
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
ORRF
ORRF
Operating Cash FlowLast quarter
$-22.8M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
$-22.8M
$74.7M
Q3 25
$-15.2M
$22.8M
Q2 25
$-10.3M
$24.5M
Q1 25
$-9.4M
$11.0M
Q4 24
$-14.6M
$35.0M
Q3 24
$13.1M
$7.5M
Q2 24
$17.4M
$6.4M
Free Cash Flow
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
$-24.9M
$70.5M
Q3 25
$-18.1M
$22.3M
Q2 25
$-13.1M
$23.7M
Q1 25
$-14.6M
$8.6M
Q4 24
$-20.5M
$33.4M
Q3 24
$4.5M
$7.1M
Q2 24
$7.9M
$6.4M
FCF Margin
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
-49.9%
108.6%
Q3 25
-43.4%
34.7%
Q2 25
-27.7%
37.9%
Q1 25
-31.2%
14.3%
Q4 24
-36.2%
54.0%
Q3 24
6.6%
11.1%
Q2 24
11.4%
19.2%
Capex Intensity
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
4.2%
6.5%
Q3 25
7.0%
0.8%
Q2 25
6.1%
1.3%
Q1 25
11.2%
3.8%
Q4 24
10.3%
2.6%
Q3 24
12.4%
0.6%
Q2 24
13.8%
0.1%
Cash Conversion
MRVI
MRVI
ORRF
ORRF
Q1 26
Q4 25
3.48×
Q3 25
1.04×
Q2 25
1.26×
Q1 25
0.61×
Q4 24
2.55×
Q3 24
Q2 24
0.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

ORRF
ORRF

Net Interest Income$49.0M76%
Noninterest Income$15.6M24%

Related Comparisons